Fund Holdings — SR ONE CAPITAL MANAGEMENT, LP

Total Portfolio Value:
$389.28M
Total Bought:
$30.98M
Total Sold:
$0
Net Transaction:
+$30.98M
Notable People:
Sr One Capital Management, Llc
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Arcellx, Inc.
COMMON STOCK
2,346,6302,346,6300$179.96M$153.94M39.54%-$26.02M
ARS Pharmaceuticals, Inc.(SPRY)4,012,9034,012,9030$42.34M$50.48M12.97%+$8.15M
Mineralys Therapeutics, Inc.(MLYS)2,016,8223,127,933+1,111,111$24.83M$49.67M12.76%+$24.84M
Zenas BioPharma, Inc.(ZBIO)4,911,5394,911,5390$40.23M$38.80M9.97%-$1.42M
CRISPR Therapeutics AG(CRSP)1,048,9511,048,9510$41.29M$35.70M9.17%-$5.59M
Design Therapeutics, Inc.(DSGN)6,526,4766,526,4760$40.27M$25.19M6.47%-$15.08M
Alumis Inc.1,959,8961,959,8960$15.40M$12.03M3.09%-$3.37M
Oculis Holding AG(OCS)0322,500+322,500$0$6.14M1.58%+$6.14M
Nkarta, Inc.(NKTX)3,333,3333,333,3330$8.30M$6.13M1.58%-$2.17M
Oruka Therapeutics, Inc.(ORKA)430,330430,3300$8.34M$4.42M1.13%-$3.93M
KALA BIO, Inc.(KALA)598,940598,9400$4.16M$3.43M0.88%-$724.7K
enGene Holdings Inc.
COM
747,750747,7500$4.97M$3.35M0.86%-$1.62M
Page 1 of 1
SR ONE CAPITAL MANAGEMENT, LP — 13F Holdings — Q1 2025 | TickerTrail